Citius Pharmaceuticals, Inc. Accounts Payable
Citius Pharmaceuticals, Inc. (CTXR) had Accounts Payable of $8.04 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $8.04M.
- 2026-03-31: Accounts Payable, Current $9.45M.
- 2025-12-31: Accounts Payable, Current $11.02M.
- 2025-09-30: Accounts Payable, Current $13.69M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.04M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $9.45M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $11.02M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $13.69M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $10.09M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $9.37M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $7.36M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $4.93M 10-K · filed 2025-12-23 | |
| 2024-06-30 | $1.66M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $2.67M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.65M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $2.93M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $3.08M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.73M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.54M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $1.17M 10-K · filed 2023-12-29 | |
| 2022-06-30 | $1.69M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.71M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.79M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $1.28M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $1.35M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.13M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $984.17K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $1.86M 10-K · filed 2021-12-15 | |
| 2020-06-30 | $1.81M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.52M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.55M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $2.71M 10-K · filed 2020-12-16 | |
| 2019-06-30 | $2.43M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.93M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.08M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $1.57M 10-K · filed 2019-12-16 | |
| 2018-06-30 | $912.34K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.40M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $561.16K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $602.43K 10-K · filed 2018-12-11 | |
| 2017-06-30 | $1.98M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.86M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $985.87K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $909.16K 10-K · filed 2017-12-13 | |
| 2016-06-30 | $309.17K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $366.69K 10-Q · filed 2016-05-20 | |
| 2015-12-31 | $458.69K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $559.15K 10-K · filed 2016-12-23 | |
| 2015-06-30 | $334.34K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $343.44K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $199.08K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $106.17K 10-K · filed 2015-12-14 | |
| 2014-06-30 | $1.48K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $495.00 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $172.49K 10-KT · filed 2014-12-29 | $198.00 10-Q · filed 2014-02-19 |
| 2013-09-30 | $11.47K 10-Q · filed 2014-08-14 | |
| 2013-06-30 | $400.00 10-Q · filed 2013-09-18 | |
| 2013-03-31 | $200.00 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $600.00 10-Q · filed 2013-02-08 | |
| 2012-09-30 | $0.00 10-K · filed 2014-02-06 | |
| 2012-06-30 | $906.00 10-Q · filed 2012-08-17 | |
| 2012-03-31 | $906.00 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $906.00 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $906.00 10-K · filed 2013-01-15 | |
| 2011-06-30 | $906.00 10-Q · filed 2011-08-26 | |
| 2010-09-30 | $0.00 10-Q · filed 2011-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |